# Haupt Pharma Wuelfing GmbH – FDA Inspection, Aug 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/haupt-pharma-wuelfing-gmbh/a2c39edb-90a8-4e62-b319-5d0670c5e908
Source feed: FDA_Inspections

> FDA inspection 1061723 of Haupt Pharma Wuelfing GmbH, August 10, 2018. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061723
- Company Name: Haupt Pharma Wuelfing GmbH
- Inspection Date: 2018-08-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- FDA Inspection 1275631 - 2023-06-06
- FDA Inspection 1088285 - 2018-12-07
- FDA Inspection 1009773 - 2017-03-17
- [FDA Inspection 931397 - 2015-06-16](https://www.keypedia.com/records/fda_inspections/haupt-pharma-wuelfing-gmbh/bbfd52ca-dd94-4b7b-9332-d8777745c031)
- [FDA Inspection 877801 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/haupt-pharma-wuelfing-gmbh/e11928da-72ea-4175-a402-6e454fbd604d)

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/sateesh-kum-sathigari/4bfbbd77-3ea5-4744-a3f5-338e4a24adba)

Company: https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8